164 related articles for article (PubMed ID: 19270026)
1. Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival.
Quaye L; Dafou D; Ramus SJ; Song H; Gentry-Maharaj A; Notaridou M; Hogdall E; Kjaer SK; Christensen L; Hogdall C; Easton DF; Jacobs I; Menon U; Pharoah PD; Gayther SA
Hum Mol Genet; 2009 May; 18(10):1869-78. PubMed ID: 19270026
[TBL] [Abstract][Full Text] [Related]
2. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.
Notaridou M; Quaye L; Dafou D; Jones C; Song H; Høgdall E; Kjaer SK; Christensen L; Høgdall C; Blaakaer J; McGuire V; Wu AH; Van Den Berg DJ; Pike MC; Gentry-Maharaj A; Wozniak E; Sher T; Jacobs IJ; Tyrer J; Schildkraut JM; Moorman PG; Iversen ES; Jakubowska A; Mędrek K; Lubiński J; Ness RB; Moysich KB; Lurie G; Wilkens LR; Carney ME; Wang-Gohrke S; Doherty JA; Rossing MA; Beckmann MW; Thiel FC; Ekici AB; Chen X; Beesley J; ; Gronwald J; Fasching PA; Chang-Claude J; Goodman MT; Chenevix-Trench G; Berchuck A; Pearce CL; Whittemore AS; Menon U; Pharoah PD; Gayther SA; Ramus SJ;
Int J Cancer; 2011 May; 128(9):2063-74. PubMed ID: 20635389
[TBL] [Abstract][Full Text] [Related]
3. The effects of common genetic variants in oncogenes on ovarian cancer survival.
Quaye L; Gayther SA; Ramus SJ; Di Cioccio RA; McGuire V; Hogdall E; Hogdall C; Blaakr J; Easton DF; Ponder BA; Jacobs I; Kjaer SK; Whittemore AS; Pearce CL; Pharoah PD; Song H
Clin Cancer Res; 2008 Sep; 14(18):5833-9. PubMed ID: 18794094
[TBL] [Abstract][Full Text] [Related]
4. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
[TBL] [Abstract][Full Text] [Related]
5. Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: intratumoral molecular heterogeneity.
Zborovskaya I; Gasparian A; Karseladze A; Elcheva I; Trofimova E; Driouch K; Trassard M; Tatosyan A; Lidereau R
Int J Cancer; 1999 Sep; 82(6):822-6. PubMed ID: 10446448
[TBL] [Abstract][Full Text] [Related]
6. LOH and mutation analysis of CDKN2 in primary human ovarian cancers.
Campbell IG; Foulkes WD; Beynon G; Davis M; Englefield P
Int J Cancer; 1995 Oct; 63(2):222-5. PubMed ID: 7591208
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
8. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
Song H; Hogdall E; Ramus SJ; Dicioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PD; Gayther SA
Clin Cancer Res; 2008 Feb; 14(4):1090-5. PubMed ID: 18281541
[TBL] [Abstract][Full Text] [Related]
9. Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.
Dafou D; Grun B; Sinclair J; Lawrenson K; Benjamin EC; Hogdall E; Kruger-Kjaer S; Christensen L; Sowter HM; Al-Attar A; Edmondson R; Darby S; Berchuck A; Laird PW; Pearce CL; Ramus SJ; Jacobs IJ; Gayther SA
Neoplasia; 2010 Jul; 12(7):579-89. PubMed ID: 20651987
[TBL] [Abstract][Full Text] [Related]
10. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
Song H; Ramus SJ; Kjaer SK; Hogdall E; Dicioccio RA; Whittemore AS; McGuire V; Hogdall C; Jacobs IJ; Easton DF; Ponder BA; Dunning AM; Gayther SA; Pharoah PD
PLoS One; 2007 Mar; 2(3):e268. PubMed ID: 17342202
[TBL] [Abstract][Full Text] [Related]
11. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic changes associated with ovarian cancer.
Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
[TBL] [Abstract][Full Text] [Related]
13. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
[TBL] [Abstract][Full Text] [Related]
14. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
15. Discovery analysis of TCGA data reveals association between germline genotype and survival in ovarian cancer patients.
Braun R; Finney R; Yan C; Chen QR; Hu Y; Edmonson M; Meerzaman D; Buetow K
PLoS One; 2013; 8(3):e55037. PubMed ID: 23555554
[TBL] [Abstract][Full Text] [Related]
16. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
[TBL] [Abstract][Full Text] [Related]
17. ERCC5 is a novel biomarker of ovarian cancer prognosis.
Walsh CS; Ogawa S; Karahashi H; Scoles DR; Pavelka JC; Tran H; Miller CW; Kawamata N; Ginther C; Dering J; Sanada M; Nannya Y; Slamon DJ; Koeffler HP; Karlan BY
J Clin Oncol; 2008 Jun; 26(18):2952-8. PubMed ID: 18565881
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.
Sun Y; Tao W; Huang M; Wu X; Gu J
J Cell Mol Med; 2017 Mar; 21(3):510-518. PubMed ID: 28233473
[TBL] [Abstract][Full Text] [Related]
19. Variation in endoglin pathway genes is associated with preeclampsia: a case-control candidate gene association study.
Bell MJ; Roberts JM; Founds SA; Jeyabalan A; Terhorst L; Conley YP
BMC Pregnancy Childbirth; 2013 Apr; 13():82. PubMed ID: 23548068
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:
Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M
Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
